Markets & Regulations

Extending plant powders

Extending plant powders

In the US this week, supplier of botanical extracts for the
pharmaceutical industry Pharmachem Laboratories announced that it
has acquired 'the largest botanical extraction facility in North
America, producing extracts for the...

Biopharma merger in UK

Biopharma merger in UK

Spotlight on the home of the celebrated pork pie in England, with
the annoucement this week that Melton Mowbray-based Bridgehead
Technologies and Pharmalicensing - two biopharmaceutical business
development companies - are to merge.

D&E to offer outsourcing

D&E to offer outsourcing

US manufacturer of vitamins, minerals, herbs and supplements
D&E Pharmaceuticals, has launched a contract manufacturing
services initiative, principally aimed at small to medium sized
nutraceutical suppliers.

Cost cutting at Axis-Shield

Cost cutting at Axis-Shield

In a bid to improve efficiency and reduce costs UK in vitro
diagnostics company Axis-Shield is to shift the manufacture of
certain products from its site in Oslo, Norway to the company's
global headquarters in Dundee, Scotland.

MSC.Software extends range

MSC.Software extends range

US provider of virtual product development (VPD) technologies
MSC.Software has come up with a range of new software and services
packages targeted at the biomedical market and medical device
manufacturers.

Modest growth for Balchem

Modest growth for Balchem

Balchem reported a small rise in net sales, up 3 per cent overall
during the first quarter of 2003, but said it was pleased with
results in light of the continued difficult economic environment.
Net earnings at the New York-based...

Cautious 2003 for DSM

Cautious 2003 for DSM

The global economic downturn marked 2003 first quarter results for
Dutch based life science company DSM but strong autonomous volume
growth boosted figures to higher than 2002.

Meeting GMP standards

Meeting GMP standards

Invensys APV, a supplier of process equipment to the pharmaceutical
industry, will demonstrate its new technologies at the upcoming
Achema 2003 exhibition in Frankfurt, Germany.

Investing in peptides

Investing in peptides

US company PPD is taking a stake in Chemokine Therapeutics, a
Canadian- and US-based biotechnology company, to continue
development of a proprietary peptide derived from a particular
chemokine that may make the peptide useful as a...

Celltech lays claims to OGS

Celltech lays claims to OGS

UK biotechnology bellwether Celltech has emerged victorious in the
bidding battle for Oxford GlycoSciences. OGS reluctantly gave in to
Celltech's pressure on 11 April, after the latter firm bought
additional holdings which brought...

HQ for Euro biotech

HQ for Euro biotech

The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.

Osmetch grows

Osmetch grows

UK developer of medical diagnostics devices Osmetech continued the
strategy to build on its healthcare diagnostics business with the
acquisition this week of the Atlanta-based 'OPTI' product line of
blood gas analysers owned...

New patent for Chiral Quest

New patent for Chiral Quest

Life science company Chiral Quest this week announced that the
non-profit organisation, the Penn State Research Foundation, has
received a US patent covering the compositions of matter and use
for a series of chiral phosphine ligands...

UK biotech collaboration

UK biotech collaboration

Two British firms, De Novo Pharmaceuticals and Peakdale Molecular,
are to enter into a joint collaboration to exploit their respective
skills in molecular design and chemistry synthesis, writes market
analysts Datamonitor this week.

New era for Roche

New era for Roche

Shareholders at Swiss pharmaceutical company Roche welcomed the
start of a new era as the company summarised recent events,
including the divestment of the vitamins business, at its annual
general meeting yesterday.

Follow us

Products

View more

Webinars